SPONDYLOARTHROPATHIES: TNF inhibitors and structural damage in ankylosing spondylitis

    loading  Checking for direct PDF access through Ovid


Whether TNF inhibitors prevent structural damage in ankylosing spondylitis remains a controversial topic, as three prospective trials failed to show any evidence to support this notion. However, data are accumulating from retrospective analyses of well-characterized cohorts of patients that could provide the solution to this controversy.Refers to Molnar C. et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann. Rheum. Dis.http://dx.doi.org/10.1136/annrheumdis-2017-211544 (2017)

    loading  Loading Related Articles